News & Views
Onyx Scientific clinches cancer research contract
Aug 26 2011
Cancer Research UK the nation’s leading cancer charity has awarded Onyx Scientific, an active pharmaceutical ingredient (API) manufacturer, a contract to develop the chemistry and perform the GMP synthesis of the API for use in a Phase 1 clinical trial.
Dr Nigel Westwood, drug supply manager at Cancer Research UK, said: “Having had a very positive experience of using Onyx Scientific’s process development and GMP manufacturing services in the past, they seemed like a strong candidate for this important project.
“Despite the fact that Cancer Research UK had to change suppliers at such a critical stage, Onyx Scientific still expect to bring the project in on time and on budget. Given their expertise in chemistry and ability to deliver, we believe they are perfect fit for the project,” added Dr Westwood.
Onyx Scientific provides outsourced facilities and expertise to help pharmaceutical and biotech companies accelerate drug candidates from discovery, through development, into Phase I/II GMP API manufacturing. The Cancer Research UK project is one of the biggest projects in the firm’s history and is expected to take around seven months to complete.
Digital Edition
Lab Asia 29.6 Dec
December 2022
In This Edition Chromatography - Optimising Viral Vector Purification Strategies with Multimodal Chromatography - Key UHPLC Characteristics Required for High throughput LC-MS - New Low Volu...
View all digital editions
Events
Feb 06 2023 Dubai, UAE
Feb 14 2023 Cologne, Germany
Feb 22 2023 Amsterdam, Netherlands
Salon International des Laboratories Lab Expo
Feb 22 2023 Tunis, Tunisia
Feb 25 2023 San Diego, CA, USA